Приказ основних података о документу

dc.creatorMilovanović, S
dc.creatorĐuriš, Jelena
dc.creatorDapcević, Aleksandra
dc.creatorMedarević, Đorđe
dc.creatorIbrić, Svetlana
dc.creatorZizović, I
dc.date.accessioned2019-09-02T12:08:41Z
dc.date.available2019-09-02T12:08:41Z
dc.date.issued2019
dc.identifier.issn0142-9418
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/3252
dc.description.abstractThe present work is aimed towards designing advanced materials by means of sustainable processes. In that sense, the utilization of supercritical CO 2 (scCO 2 ) for processing of pharmaceutical polymers (Soluplus ® , Eudragit ® , and hydroxypropyl methylcellulose acetate succinate), alone and with an addition of cardiovascular drug Carvedilol, was explored. Employed single-step static scCO 2 process (pressure of 30 MPa and temperature of 100 °C for 2 h) enabled fabrication of solvent-free polymeric foams and Carvedilol solid dispersions with controlled microstructure and average pore diameter of 101–257 μm suitable for application in the pharmaceutical industry. ScCO 2 did not remain in the foams after processing or affected the polymer composition, while Carvedilol formed hydrogen bonds with the polymers. Carvedilol was molecularly dispersed in the fabricated solid dispersions and its transition from the crystalline to amorphous form was complete. Korsmeyer-Peppas model was successfully used for the mathematical description of Carvedilol dissolution from solid dispersions. The dissolution rate of Carvedilol in acidic medium was significantly enhanced by its dispersion in tested polymers using the proposed high-pressure method.en
dc.publisherElsevier Ltd
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/45017/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/Technological Development (TD or TR)/34007/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/45007/RS//
dc.rightsrestrictedAccess
dc.sourcePolymer Testing
dc.subjectCarvedilolen
dc.subjectEudragit ®en
dc.subjectHPMC-ASen
dc.subjectSolid dispersionen
dc.subjectSoluplus ®en
dc.subjectSupercritical CO 2en
dc.titleSoluplus ® , Eudragit ® , HPMC-AS foams and solid dispersions for enhancement of Carvedilol dissolution rate prepared by a supercritical CO 2 processen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractЗизовић, И; Ђуриш, Јелена; Дапцевић, Aлександра; Ибрић, Светлана; Медаревић, Ђорђе; Миловановић, С;
dc.citation.volume76
dc.citation.spage54
dc.citation.epage64
dc.citation.other76: 54-64
dc.citation.rankM21
dc.identifier.wos000479182700006
dc.identifier.doi10.1016/j.polymertesting.2019.03.001
dc.identifier.scopus2-s2.0-85062807468
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу